Iris Bincovich
Tracked across 4 events · 29 articles · First seen Jul 29, 2026 · Last active Sep 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: CEO of Innocan Pharma Corporation; commented on the milestone.
Jul 29, 2026 · 7 articles
Business
Impact: Iris Bincovich, CEO of Innocan Pharma, commented on the results, highlighting the strength of B.I. Sky's business and the impact of tariff policies.
Aug 31, 2026 · 8 articles
Business
Impact: Iris Bincovich, CEO of Innocan, is listed as a contact but has no direct role in this announcement.
Aug 05, 2026 · 7 articles
Business
Innocan Pharma Corporation announced on September 9, 2026 its intention to complete a private placement of up to 535,000 units at C$1.87 per unit, for gross proceeds of up to C$1,000,000. Each unit consists of…
Impact: Iris Bincovich is the CEO of Innocan Pharma and is listed as a contact for the offering, representing the company in the private placement.
Sep 09, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Iris Bincovich live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard